Your browser doesn't support javascript.
loading
Exposure-response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors.
Krishnatry, Anu Shilpa; Hanze, Eva; Bergsma, Tim; Dhar, Arindam; Prohn, Marita; Ferron-Brady, Geraldine.
Afiliação
  • Krishnatry AS; Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Hanze E; qPharmetra LLC, Nijmegen, the Netherlands.
  • Bergsma T; qPharmetra LLC, Nijmegen, the Netherlands.
  • Dhar A; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Prohn M; qPharmetra LLC, Nijmegen, the Netherlands.
  • Ferron-Brady G; Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
CPT Pharmacometrics Syst Pharmacol ; 11(5): 556-568, 2022 05.
Article em En | MEDLINE | ID: mdl-34648693
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Síndrome do QT Longo / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Síndrome do QT Longo / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article